Biomarker blood test confirms remission in patients with HPV+ oral cancer
(American Society for Radiation Oncology) A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC) are free from cancer following radiation therapy. Findings will be presented today at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2018 Category: Cancer & Oncology Source Type: news
Patients with HPV-positive oropharynx cancer should receive chemoradiation
(European Society for Medical Oncology) Patients with human papilloma virus (HPV)-positive throat cancer should receive chemoradiotherapy rather than cetuximab with radiotherapy, according to late-breaking research reported at the ESMO 2018 Congress in Munich. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 22, 2018 Category: International Medicine & Public Health Source Type: news
RT and Surgery Appear Equally Viable for Oropharyngeal Cancer
(MedPage Today) -- But chemo add-on to RT was tied to increased gastrostomy dependence (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - September 25, 2018 Category: Radiology Source Type: news
Trends in HPV-Associated Cancers -- United States, 1999-2015 Trends in HPV-Associated Cancers -- United States, 1999-2015
This report examined trends in cervical cancer, as well as oropharyngeal, vulvar, vaginal, penile, and anal cancers.Morbidity & Mortality Weekly Report (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Late Lower Cranial Neuropathy in Oropharyngeal Cancer Patients
Survivors of oropharyngeal cancers who developed late lower cranial neuropathy reported having worse treatment-related symptoms. (Source: CancerNetwork)
Source: CancerNetwork - September 14, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news
Total of 43,371 New Cases of HPV - Associated Cancers in 2015
Decreases in cervical cancer, vaginal SCC from 1999 to 2015; increases in oropharyngeal, anal, vulvar SCC (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 11, 2018 Category: Cancer & Oncology Tags: Family Medicine, Gynecology, Infections, Internal Medicine, Nursing, Oncology, Pathology, Journal, Source Type: news
Total of 43,371 New Cases of HPV-Associated Cancers in 2015
TUESDAY, Sept. 11, 2018 -- A total of 43,371 new cases of human papillomavirus (HPV)-associated cancers were reported in 2015, with oropharyngeal squamous cell carcinoma (SCC) being the most common HPV-associated cancer, according to research... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 11, 2018 Category: Pharmaceuticals Source Type: news
Test Oropharyngeal Cancers for HPV
(MedPage Today) -- ASCO endorses CAP guideline (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 10, 2018 Category: American Health Source Type: news
Top HPV-Associated Cancer Is Now Oropharyngeal
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 24, 2018 Category: General Medicine Source Type: news
CDC: Top HPV-Associated Cancer Is Now Oropharyngeal CDC: Top HPV-Associated Cancer Is Now Oropharyngeal
Also, the Centers for Disease Control and Prevention reports that over the past 15 years, women ' s HPV-associated cancers are in decline and men ' s are on the rise.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
No Change in Standard of Care for HPV+ Oropharyngeal Cancer No Change in Standard of Care for HPV+ Oropharyngeal Cancer
Interim results of a large phase III trial showed that patients treated with a cetuximab regimen has worse survival than those treated with cisplatin plus radiation therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer
. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - August 14, 2018 Category: American Health Source Type: news
Cetuximab+RT found to be inferior to standard treatment in HPV+ oropharyngeal cancer
(NIH/National Cancer Institute) An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment with radiation therapy and cetuximab is associated with worse overall and progression-free survival compared to the current standard treatment with radiation and cisplatin. The trial was designed to see if cetuximab with radiation would be less toxic than cisplatin with radiation without compromising survival for patients with the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2018 Category: Cancer & Oncology Source Type: news
Older Adults Increasingly Have HPV + Oropharyngeal Cancers
Regardless of age, favorable survival conferred by an HPV - positive tumor status (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 13, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pathology, Geriatrics, Journal, Source Type: news
Older Adults Increasingly Have HPV & #43; Oropharyngeal Cancers
WEDNESDAY, June 13, 2018 -- Human papillomavirus (HPV)-positive oropharyngeal cancers are increasing among older adults, according to a study published online April 30 in Cancer.
Melina J. Windon, M.D., from Johns Hopkins University in Baltimore,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 13, 2018 Category: Pharmaceuticals Source Type: news
